341 related articles for article (PubMed ID: 21161283)
1. Efficacy of eculizumab in a patient with factor-H-associated atypical hemolytic uremic syndrome.
Lapeyraque AL; Frémeaux-Bacchi V; Robitaille P
Pediatr Nephrol; 2011 Apr; 26(4):621-4. PubMed ID: 21161283
[TBL] [Abstract][Full Text] [Related]
2. Eculizumab in atypical hemolytic uremic syndrome: long-term clinical course and histological findings.
Tschumi S; Gugger M; Bucher BS; Riedl M; Simonetti GD
Pediatr Nephrol; 2011 Nov; 26(11):2085-8. PubMed ID: 21877169
[TBL] [Abstract][Full Text] [Related]
3. Tailored eculizumab therapy in the management of complement factor H-mediated atypical hemolytic uremic syndrome in an adult kidney transplant recipient: a case report.
Xie L; Nester CM; Reed AI; Zhang Y; Smith RJ; Thomas CP
Transplant Proc; 2012 Dec; 44(10):3037-40. PubMed ID: 23195022
[TBL] [Abstract][Full Text] [Related]
4. Complement inhibitor eculizumab in atypical hemolytic uremic syndrome.
Mache CJ; Acham-Roschitz B; Frémeaux-Bacchi V; Kirschfink M; Zipfel PF; Roedl S; Vester U; Ring E
Clin J Am Soc Nephrol; 2009 Aug; 4(8):1312-6. PubMed ID: 19556379
[TBL] [Abstract][Full Text] [Related]
5. Successful 7-Year Eculizumab Treatment of Plasmapheresis-Resistant Recurrent Atypical Hemolytic-Uremic Syndrome due to Complement Factor H Hybrid Gene: A Case Report.
Vondrák K; Seeman T
Transplant Proc; 2018 Apr; 50(3):967-970. PubMed ID: 29661469
[TBL] [Abstract][Full Text] [Related]
6. Eculizumab in anti-factor h antibodies associated with atypical hemolytic uremic syndrome.
Diamante Chiodini B; Davin JC; Corazza F; Khaldi K; Dahan K; Ismaili K; Adams B
Pediatrics; 2014 Jun; 133(6):e1764-8. PubMed ID: 24843055
[TBL] [Abstract][Full Text] [Related]
7. Neonatal onset atypical hemolytic uremic syndrome successfully treated with eculizumab.
Besbas N; Gulhan B; Karpman D; Topaloglu R; Duzova A; Korkmaz E; Ozaltin F
Pediatr Nephrol; 2013 Jan; 28(1):155-8. PubMed ID: 22956028
[TBL] [Abstract][Full Text] [Related]
8. Insights from the use in clinical practice of eculizumab in adult patients with atypical hemolytic uremic syndrome affecting the native kidneys: an analysis of 19 cases.
Fakhouri F; Delmas Y; Provot F; Barbet C; Karras A; Makdassi R; Courivaud C; Rifard K; Servais A; Allard C; Besson V; Cousin M; Châtelet V; Goujon JM; Coindre JP; Laurent G; Loirat C; Frémeaux-Bacchi V
Am J Kidney Dis; 2014 Jan; 63(1):40-8. PubMed ID: 24021908
[TBL] [Abstract][Full Text] [Related]
9. Atypical hemolytic uremic syndrome.
Kavanagh D; Goodship TH
Curr Opin Hematol; 2010 Sep; 17(5):432-8. PubMed ID: 20613506
[TBL] [Abstract][Full Text] [Related]
10. Atypical Hemolytic Uremic Syndrome: A Meta-Analysis of Case Reports Confirms the Prevalence of Genetic Mutations and the Shift of Treatment Regimens.
Krishnappa V; Gupta M; Elrifai M; Moftakhar B; Ensley MJ; Vachharajani TJ; Sethi SK; Raina R
Ther Apher Dial; 2018 Apr; 22(2):178-188. PubMed ID: 29250893
[TBL] [Abstract][Full Text] [Related]
11. An Ex Vivo Test of Complement Activation on Endothelium for Individualized Eculizumab Therapy in Hemolytic Uremic Syndrome.
Galbusera M; Noris M; Gastoldi S; Bresin E; Mele C; Breno M; Cuccarolo P; Alberti M; Valoti E; Piras R; Donadelli R; Vivarelli M; Murer L; Pecoraro C; Ferrari E; Perna A; Benigni A; Portalupi V; Remuzzi G
Am J Kidney Dis; 2019 Jul; 74(1):56-72. PubMed ID: 30851964
[TBL] [Abstract][Full Text] [Related]
12. Three months interval therapy of Eculizumab in a patient with atypical hemolytic uremic syndrome with hybrid CFHR1/CFH gene.
Alobaidi S; AlDabbagh A; Alamoudi A; Almowarey M; Akl A
CEN Case Rep; 2019 May; 8(2):139-143. PubMed ID: 30715674
[TBL] [Abstract][Full Text] [Related]
13. Eculizumab as rescue therapy for atypical hemolytic uremic syndrome with normal platelet count.
Dorresteijn EM; van de Kar NC; Cransberg K
Pediatr Nephrol; 2012 Jul; 27(7):1193-5. PubMed ID: 22399074
[TBL] [Abstract][Full Text] [Related]
14. Maintenance of kidney function following treatment with eculizumab and discontinuation of plasma exchange after a third kidney transplant for atypical hemolytic uremic syndrome associated with a CFH mutation.
Davin JC; Gracchi V; Bouts A; Groothoff J; Strain L; Goodship T
Am J Kidney Dis; 2010 Apr; 55(4):708-11. PubMed ID: 19854549
[TBL] [Abstract][Full Text] [Related]
15. Terminal Complement Inhibitor Eculizumab in Adult Patients With Atypical Hemolytic Uremic Syndrome: A Single-Arm, Open-Label Trial.
Fakhouri F; Hourmant M; Campistol JM; Cataland SR; Espinosa M; Gaber AO; Menne J; Minetti EE; Provôt F; Rondeau E; Ruggenenti P; Weekers LE; Ogawa M; Bedrosian CL; Legendre CM
Am J Kidney Dis; 2016 Jul; 68(1):84-93. PubMed ID: 27012908
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of eculizumab in childhood atypical hemolytic uremic syndrome in Japan.
Ito N; Hataya H; Saida K; Amano Y; Hidaka Y; Motoyoshi Y; Ohta T; Yoshida Y; Terano C; Iwasa T; Kubota W; Takada H; Hara T; Fujimura Y; Ito S
Clin Exp Nephrol; 2016 Apr; 20(2):265-72. PubMed ID: 26156042
[TBL] [Abstract][Full Text] [Related]
17. Favorable long-term outcomes of isolated liver transplantation in a child with atypical hemolytic uremic syndrome caused by a novel complement factor H mutation
.
Cho H; Lee Y
Clin Nephrol; 2017 Jul; 88(1):52-56. PubMed ID: 28502324
[TBL] [Abstract][Full Text] [Related]
18. Eculizumab Modifies Outcomes in Adults with Atypical Hemolytic Uremic Syndrome with Acute Kidney Injury.
Cao M; Leite BN; Ferreiro T; Calvo M; Fernández C; Alonso Á; Rodriguez A; Salvador P; Seijo R; Pita S; Arjona E; Rodríguez de Córdoba S; Valdés Cañedo F
Am J Nephrol; 2018; 48(3):225-233. PubMed ID: 30205388
[TBL] [Abstract][Full Text] [Related]
19. Long-term eculizumab improves clinical outcomes in atypical hemolytic uremic syndrome.
Vilalta R; Lara E; Madrid A; Chocron S; Muñoz M; Casquero A; Nieto J
Pediatr Nephrol; 2012 Dec; 27(12):2323-6. PubMed ID: 22890512
[TBL] [Abstract][Full Text] [Related]
20. Use of eculizumab and plasma exchange in successful combined liver-kidney transplantation in a case of atypical HUS associated with complement factor H mutation.
Tran H; Chaudhuri A; Concepcion W; Grimm PC
Pediatr Nephrol; 2014 Mar; 29(3):477-80. PubMed ID: 24221349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
